# Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer

> **NCT06301464** · — · ACTIVE_NOT_RECRUITING · sponsor: **Seoul National University Bundang Hospital** · enrollment: 24000 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06301464
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2003-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 24000 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301464, "Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06301464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*